Efficacy and Safety of Combination Eribulin + Pembrolizumab

obr has 860 videos Subscribe Here

Description: Sara Tolaney, MD, Associate Director, Susan F. Smith Center for Women’s Cancers, Director Clinical Trials, Breast Oncology, Associate Professor of Medicine, Harvard Medical School elaborates on the efficacy and safety of combination eribulin and pembrolizumab in metastatic breast cancer.
Shared By : obr
Posted on : 07/02/19
Added : 14 days ago
Category : Breast Cancer